Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/22/2012 | US20120296443 Sericin extracted fabrics |
11/22/2012 | US20120296352 Sericin extracted fabrics |
11/22/2012 | US20120296351 Sericin extracted fabrics |
11/22/2012 | US20120295975 Methods of treating inflammatory conditions |
11/22/2012 | US20120295964 Retrograde transport viral vector system having envelope comprising fused glycoprotein |
11/22/2012 | US20120295959 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1 |
11/22/2012 | US20120295958 Modulation of glucagon receptor expression |
11/22/2012 | US20120295955 Rna antagonist compounds for the modulation of her3 |
11/22/2012 | US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
11/22/2012 | US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 |
11/22/2012 | US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
11/22/2012 | US20120295949 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of tumor involving chromosomal rearrangements |
11/22/2012 | US20120295926 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same |
11/22/2012 | US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
11/22/2012 | US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses |
11/22/2012 | US20120295890 Glycosaminoglycan inhibitors |
11/22/2012 | US20120295880 Compounds With Modifying Activity Enhanced Under Hypoxic Conditions |
11/22/2012 | US20120295804 Compositions and Methods for Diagnosis and Treatment of Breast Cancer |
11/22/2012 | US20120295354 Sulfonylurea-responsive repressor proteins |
11/22/2012 | US20120295353 Methods of making and using polymers and compositions |
11/22/2012 | US20120295352 Systems and Methods for Expanding High Density Non-Adherent Cells |
11/22/2012 | US20120295351 Method for cloning pluripotent stem cells |
11/22/2012 | US20120295350 Prospective Identification and Characterization of Breast Cancer Stem Cells |
11/22/2012 | US20120295349 Mammal dedicated cell line from human hepatocellular carcinoma cell |
11/22/2012 | US20120295348 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling |
11/22/2012 | US20120295347 Methods and Compositions for Producing Endothelial Progenitor Cells from Pluripotent Stem Cells |
11/22/2012 | US20120295346 Methods and compositions for modulating membrane potential to influence cell behavior |
11/22/2012 | US20120295345 Apparatuses and related methods for delivering biological material into a cell |
11/22/2012 | US20120295344 Stem Cell Fusion Model of Carcinogenesis |
11/22/2012 | US20120295326 Luciferases and methods for making and using the same |
11/22/2012 | US20120295310 Nucleic acids encoding anti-il-23 antibodies |
11/22/2012 | US20120295305 Cysteine Protease Autoprocessing of Fusion Proteins |
11/22/2012 | US20120295289 Device and method for culturing cells |
11/22/2012 | US20120295246 Blood cell sorting methods and systems |
11/22/2012 | US20120295245 Dermal micro-organs, methods and appratuses for producing and using the same |
11/22/2012 | US20120295012 Melon variety nun 02002 |
11/22/2012 | US20120295011 Banana promoters |
11/22/2012 | US20120294956 Inhibition of dynamin related protein 1 to promote cell death |
11/22/2012 | US20120294949 Methods of producing stem cell conditioned media to treat mammalian injuries or insults |
11/22/2012 | US20120294932 Prostate Carcinogenesis Predictor |
11/22/2012 | US20120294906 Sericin extracted fabrics |
11/22/2012 | US20120294886 Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
11/22/2012 | US20120294883 Oligomeric receptor ligand pair member complexes |
11/22/2012 | US20120294880 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
11/22/2012 | US20120294879 Consensus sequence for influenza a virus |
11/22/2012 | US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
11/22/2012 | US20120294874 Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof |
11/22/2012 | US20120294870 Compositions and methods for diagnosis and treatment of tumors |
11/22/2012 | US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation |
11/22/2012 | US20120294861 Fgfr1 agonists and methods of use |
11/22/2012 | US20120294859 Cancer stem cell markers and uses thereof |
11/22/2012 | US20120294857 Monomeric Bi-Specific Fusion Protein |
11/22/2012 | US20120294842 Platelet Additive Solution Having a Sialidase Inhibitor |
11/22/2012 | US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins |
11/22/2012 | US20120294837 Methods of isolating and culturing mesenchymal stem cells |
11/22/2012 | US20120294836 High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration |
11/22/2012 | US20120294835 Substituted pyridines and pyrimidines |
11/22/2012 | US20120294826 Methods, kits and compositions for ameliorating adverse effects associated with transfusion of aged red blood cells |
11/22/2012 | US20120294823 Method for preparing silk sericin-PVA scaffold using genipin as crosslinking agent |
11/22/2012 | US20120294805 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof |
11/22/2012 | US20120294800 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
11/22/2012 | US20120294797 Anti-cgrp compositions and use thereof |
11/22/2012 | US20120294796 Antibodies Reactive with B7-H3 and Uses Thereof |
11/22/2012 | CA2836637A1 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells |
11/22/2012 | CA2836578A1 Passaging and harvesting formulation and method for human pluripotent stem cells |
11/22/2012 | CA2836488A1 Methods for treating obesity and/or metabolic syndrome |
11/22/2012 | CA2836465A1 Stable electrically active neurons from adult tissue |
11/22/2012 | CA2836288A1 Porcine reproductive and respiratory syndrome virus resistant animals |
11/22/2012 | CA2836102A1 Mesenchymal stromal cell populations and methods of making same |
11/22/2012 | CA2836073A1 Method for producing polyploidized megakaryocyte and platelets |
11/22/2012 | CA2835825A1 Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells |
11/22/2012 | CA2835053A1 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii |
11/22/2012 | CA2828874A1 Thermostable variants of fibroblast growth factors |
11/21/2012 | EP2524034A1 Bioengineered tissue constructs and methods for producing and using thereof |
11/21/2012 | EP2524032A2 Materials and methods for producing cell-surface directed and associated non-naturally occurring bioinorganic membranes and uses thereof |
11/21/2012 | EP2524031A1 Human and murine stem-cell lines: models of endothelial cell precursors |
11/21/2012 | EP2524030A1 Organ-specific feline endothelial cells and uses thereof |
11/21/2012 | EP2524023A1 Novel mannanase variants |
11/21/2012 | EP2523686A2 Liver targeting domain antibodies |
11/21/2012 | EP2523678A2 Wnt antagonists and methods of treatment and screening |
11/21/2012 | CN102791857A Mouse artificial chromosome vector |
11/21/2012 | CN102791851A Methods for purifying cells derived from pluripotent stem cells |
11/21/2012 | CN102791293A Liver targeting molecules |
11/21/2012 | CN102791276A Cell preparation containing mesenchymal stem cells, and method for producing same |
11/21/2012 | CN102787120A Genetic transformation of jatropha curcas |
11/21/2012 | CN102787119A Products and methods for treatment and/or prevention of virus infections |
11/21/2012 | CN102787108A Protein derived from Trichoderma reesei and gene application thereof |
11/21/2012 | CN102787105A Cotton uridine diphosphate-glucose dehydrogenase gene UGD6, its encoding protein and application |
11/21/2012 | CN102787098A Human gastric carcinoma multi-drug-resistance cell line |
11/21/2012 | CN102787097A Modified dendritic cell and vaccine containing the same |
11/21/2012 | CN102787096A Extraction method of mouse liver sinusoidal endothelial cells |
11/21/2012 | CN102787095A Method for cultivating rat primary airway epithelial cells |
11/21/2012 | CN102787094A Culture medium, kit used for culturing cells and method for culturing cells |
11/21/2012 | CN102787093A Culture medium, kit used for culturing cells and method for culturing cells |
11/21/2012 | CN102787092A Culture medium, cell culture kit and cell culture method |
11/21/2012 | CN102787066A Enclosed perfusion-type photobioreactor |
11/21/2012 | CN102786599A Application of rice transcription factor Os05g39950 gene |
11/21/2012 | CN102786598A Anti-ERCC1 monoclonal antibody 4F9 and application |
11/21/2012 | CN102786597A Anti ERCC1 monoclonal antibody 2E12 and application |
11/21/2012 | CN102786595A Anti-CD5 monoclonal antibody and purpose thereof |